These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1905587)

  • 1. The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals.
    Stine KC; Tyler DS; Stanley SD; Bartlett JA; Bolognesi DP; Weinhold KJ
    Cell Immunol; 1991 Aug; 136(1):165-72. PubMed ID: 1905587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2-inducible natural immune (lymphokine-activated killer cell) responses as a functional correlate of progression to AIDS.
    Brenner BG; Gornitsky M; Wainberg MA
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):538-44. PubMed ID: 8556498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective natural immunity: an early manifestation of human immunodeficiency virus infection.
    Ullum H; Gøtzsche PC; Victor J; Dickmeiss E; Skinhøj P; Pedersen BK
    J Exp Med; 1995 Sep; 182(3):789-99. PubMed ID: 7650485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.
    Tyler DS; Stanley SD; Bartlett JA; Bolognesi DP; Weinhold KJ
    J Surg Res; 1998 Oct; 79(2):115-20. PubMed ID: 9758725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual role of TNF-alpha in NK/LAK cell-mediated lysis of chronically HIV-infected U1 cells. Concomitant enhancement of HIV expression and sensitization of cell-mediated lysis.
    Fortis C; Biswas P; Soldini L; Veglia F; Careddu AM; Delfanti F; Mantelli B; Murone M; Lazzarin A; Poli G
    Eur J Immunol; 1999 Nov; 29(11):3654-62. PubMed ID: 10556821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of breast cancer, HIV-1 infection and chemotherapy on inducible natural immunity.
    Brenner BG; Vo C; Wainberg MA
    Leukemia; 1994 Apr; 8 Suppl 1():S183-5. PubMed ID: 8152288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of human NK cells and generation of LAK activity.
    Whiteside TL
    Curr Protoc Immunol; 2001 May; Chapter 7():Unit 7.7. PubMed ID: 18432847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminution of inducible lymphokine-activated killer cell activity in individuals with AIDS-related disorders.
    Gryllis C; Wainberg MA; Gornitsky M; Brenner B
    AIDS; 1990 Dec; 4(12):1205-12. PubMed ID: 2088399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients.
    Lucey DR; Pinto LA; Bethke FR; Rusnak J; Melcher GP; Hashemi FN; Landay AL; Kessler HA; Paxton RJ; Grabstein K; Shearer GM
    Clin Diagn Lab Immunol; 1997 Jan; 4(1):43-8. PubMed ID: 9008279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
    Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
    Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in natural immunity during the course of HIV-1 infection.
    Brenner BG; Gryllis C; Gornitsky M; Wainberg MA
    Clin Exp Immunol; 1993 Aug; 93(2):142-8. PubMed ID: 7688673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases.
    Brenner BG; Gryllis C; Wainberg MA
    J Leukoc Biol; 1991 Dec; 50(6):628-40. PubMed ID: 1940615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
    Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
    Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.
    Flexman JP; Manning LS; Robinson BW
    Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of lymphokine-activated killer activity during HIV infection: role of HIV-1 gp41 synthetic peptides.
    Cauda R; Tumbarello M; Ortona L; Kennedy RC; Shuler KR; Chanh TC; Kanda P
    Nat Immun Cell Growth Regul; 1990; 9(6):366-75. PubMed ID: 2087245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii.
    Subauste CS; Dawson L; Remington JS
    J Exp Med; 1992 Dec; 176(6):1511-9. PubMed ID: 1460415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Beroukas C; Stathopoulos GP; Papamichail M
    Cancer; 1995 Oct; 76(7):1253-60. PubMed ID: 8630906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.